The risk of cardiovascular adverse effects associated with JAK inhibitors in rheumatoid arthritis: a protocol for a systematic review and meta-analysis

07/12/2020
02/04/2024
EU PAS number:
EUPAS35534
Study
Finalised
Documents
Study protocol
Initial protocol
English (375.82 KB - PDF) View document
Study results
Study report
Other information